The fund owned 27,930 shares of the pharmaceutical company's stock after buying an additional 2,310 shares during the period. LLC's holdings in GlaxoSmithKline PLC were worth $495,000 as of its most recent filing with the SEC.
Several other hedge funds also recently made changes to their positions in the company. Proficio Capital Partners LLC grew its stake in GlaxoSmithKline PLC by 16.1% in the 2nd quarter. LS Investment Advisors LLC raised its stake in shares of GlaxoSmithKline PLC by 167.5% in the second quarter. Finally, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA increased its holdings in shares of GlaxoSmithKline PLC by 1.9% in the 2nd quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 3,374 shares of the pharmaceutical company's stock valued at $137,000 after buying an additional 64 shares during the last quarter. Carroll Financial Associates Inc. now owns 8,690 shares of the pharmaceutical company's stock valued at $374,000 after acquiring an additional 35 shares during the period. Advisory Services Network LLC grew its stake in GlaxoSmithKline PLC by 24.2% in the 2nd quarter. In the last three months, insiders bought 1,576 shares of company stock worth $2,400,376. Hedge funds and other institutional investors own 8.48% of the company's stock. GlaxoSmithKline plc has a 12 month low of GBX 1,315.50 ($17.30) and a 12 month high of GBX 1,724.50 ($22.68). That compares with the recent volume average of 3.09 million. GlaxoSmithKline PLC has a one year low of $37.20 and a one year high of $45.58. The company reported GBX 32.50 ($0.43) EPS for the quarter, topping the consensus estimate of GBX 31.80 ($0.42) by GBX 0.70 ($0.01). The stock has a market cap of $94.62 billion, a P/E ratio of 259.27 and a beta of 0.90. Shareholders of record on Friday, November 10th will be given a dividend of $0.5037 per share. This represents a $2.01 dividend on an annualized basis and a dividend yield of 5.76%. The ex-dividend date is Thursday, November 9th. Trading volume for GlaxoSmithKline plc was 5.18 Million in its previous trading session. GlaxoSmithKline PLC's payout ratio is now 163.12%.
A must buy stock list of the day: Henry Schein, Inc. (HSIC)
The sales growth rate for a stock is a measure of how the stock's sales per share (SPS) has grown over a specific period of time. TRADEMARK VIOLATION NOTICE: This article was posted by TrueBlueTribune and is the property of of TrueBlueTribune.
A number of analysts have recently commented on GSK shares. Morgan Stanley set a GBX 1,450 ($19.07) price objective on shares of GlaxoSmithKline plc and gave the company a sell rating in a report on Monday, November 6th. In the latest earnings report the EPS was $1.25 with 4.92B shares now outstanding. Citigroup Inc. restated a "neutral" rating on shares of GlaxoSmithKline PLC in a research note on Thursday, July 27th. Liberum Capital reaffirmed a "buy" rating and set a GBX 1,760 ($23.15) target price on shares of GlaxoSmithKline plc in a report on Wednesday, October 25th. J P Morgan Chase & Co reissued a "neutral" rating and issued a GBX 1,570 ($20.65) price target on shares of GlaxoSmithKline plc in a report on Monday, October 23rd. Three research analysts have rated the stock with a sell rating, twelve have issued a hold rating and six have given a buy rating to the company's stock. GlaxoSmithKline PLC now has a consensus rating of "Hold" and a consensus price target of $44.33.
In other news, insider Urs Rohner bought 473 shares of the stock in a transaction that occurred on Wednesday, October 25th. The shares were acquired at an average cost of GBX 1,518 ($19.97) per share, for a total transaction of £7,180.14 ($9,443.82). The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. The trend for the past 10-days shows that the company was in BEARISH territory while an analysis of the last 40-Day trend shows a BEARISH signal.
Analysts See $-0.23 EPS for Pure Storage Inc (PSTG)
The company reported ($0.10) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.15) by $0.05. Finally, California State Teachers Retirement System increased its position in Pure Storage by 110.1% in the second quarter.
ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another website, it was copied illegally and reposted in violation of global copyright legislation. The Gross Margin Score of GlaxoSmithKline plc (LSE:GSK) is 29.
GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. The company operates in the Healthcare sector with a market capitalization of 86.33 Million.
Small Business Optimism Continued Post-Trump Election Surge in October
Four of the Index components rose last month, while five declined only slightly and one remained unchanged. A net 23 percent of owners said they consider now a good time to expand, also up six points.